|
1
|
Levin DB, Wilson K, Valadares de Amorim G,
Webber J, Kenny P and Kusser W: Detection of p53 mutations in
benign and dysplastic nevi. Cancer Res. 55:4278–4282.
1995.PubMed/NCBI
|
|
2
|
Wallack MK, Sivanandham M, Balch CM, Urist
MM, Bland KI, Murray D, Robinson WA, Flaherty LE, Richards JM,
Bartolucci AA, et al: A phase III randomized, doúble-blind,
multiinstitutional trial of vaccinia melanoma oncolysate-active
specific immunotherapy for patients with stage II melanoma. Cancer.
75:34–42. 2015. View Article : Google Scholar
|
|
3
|
Busam KJ, Berwick M, Blessing K, Fandrey
K, Kang S, Karaoli T, Fine J, Cochran AJ, White WL, Rivers J, et
al: Tumor vascularity is not a prognostic factor for malignant
melanoma of the skin. Am J Pathol. 147:1049–1056. 1995.PubMed/NCBI
|
|
4
|
Surhone LM, Tennoe MT and Henssonow SF:
Treatment and prognosis of melanoma. Betascript Publishing.
2010.
|
|
5
|
Balch CM, Murad TM, Soong SJ, Ingalls AL,
Halpern NB and Maddox WA: A multifactorial analysis of melanoma:
Prognostic histopathological features comparing Clark's and
Breslow's staging methods. Ann Surg. 188:732–742. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yarmishyn AA and Kurochkin IV: Long
noncoding RNAs: A potential novel class of cancer biomarkers. Front
Genet. 6:1452015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schmidt K, Joyce CE, Buquicchio F, Brown
A, Ritz J, Distel RJ, Yoon CH and Novina CD: The lncRNA SLNCR1
mediates melanoma invasion through a conserved SRA1-like Region.
Cell Rep. 15:2025–2037. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wei Y, Sun Q, Zhao L, Wu J, Chen X, Wang
Y, Zang W and Zhao G: LncRNA UCA1-miR-507-FOXM1 axis is involved in
cell proliferation, invasion and G0/G1 cell cycle arrest in
melanoma. Med Oncol. 33:882016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yong S, Cheng H, Wang G, Yu G, Zhang D,
Wang Y, Fan W and Yang W: Deregulation of miR-183 promotes melanoma
development via lncRNA MALAT1 regulation and ITGB1 signal
activation. Oncotarget. 8:3509–3518. 2017.PubMed/NCBI
|
|
10
|
Liu C and Lin J: Long noncoding RNA
ZEB1-AS1 acts as an oncogene in osteosarcoma by epigenetically
activating ZEB1. Am J Transl Res. 8:4095–4105. 2016.PubMed/NCBI
|
|
11
|
Lv QL, Hu L, Chen SH, Sun B, Fu ML, Qin
CZ, Qu Q, Wang GH, He CJ and Zhou HH: A long noncoding RNA ZEB1-AS1
promotes tumorigenesis and predicts poor prognosis in Glioma. Int J
Mol Sci. 17(pii): E14312016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Su W, Xu M, Chen X, Chen N, Gong J, Nie L,
Li L, Li X, Zhang M and Zhou Q: Long noncoding RNA ZEB1-AS1
epigenetically regulates the expressions of ZEB1 and downstream
molecules in prostate cancer. Mol Cancer. 16:1422017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li L, Wang QF, Zou ML, He XA and Lv JJ:
Overexpressed lncRNA ZEB1-AS1 promotes cell invasion and
angiogenesis through Wnt/β-catenin signaling in non-small cell lung
cancer. Int J Clin Exp Patho. 10:3990–3997. 2017.
|
|
14
|
Li T, Xie J, Shen C, Cheng D, Shi Y, Wu Z,
Deng X, Chen H, Shen B, Peng C, et al: Upregulation of long
noncoding RNA ZEB1-AS1 promotes tumor metastasis and predicts poor
prognosis in hepatocellular carcinoma. Oncogene. 35:1575–1584.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu B, Ye B, Yang L, Zhu X, Huang G, Zhu
P, Du Y, Wu J, Qin X, Chen R, et al: Long noncoding RNA lncKdm2b is
required for ILC3 maintenance by initiation of Zfp292 expression.
Nat Immunol. 18:499–508. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dalby B, Cates S, Harris A, Ohki EC,
Tilkins ML, Price PJ and Ciccarone VC: Advanced transfection with
Lipofectamine 2000 reagent: primary neurons, siRNA, and
high-throughput applications. Methods. 33:95–103. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang J, Dong Y, Wang X, Ma H, Sheng Z, Li
G, Lu G, Sugimura H and Zhou X: Expression of EphA1 in gastric
carcinomas is associated with metastasis and survival. Oncol Rep.
24:1577–1584. 2010.PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xiao B, Zhu ED, Li N, Lu DS, Li W, Li BS,
Zhao YL, Mao XH, Guo G, Yu PW and Zou QM: Increased miR-146a in
gastric cancer directly targets SMAD4 and is involved in modulating
cell proliferation and apoptosis. Oncol Rep. 27:559–566.
2012.PubMed/NCBI
|
|
20
|
Li J, Li Z, Leng K, Xu Y, Ji D, Huang L,
Cui Y and Jiang X: ZEB1-AS1: A crucial cancer-related long
non-coding RNA. Cell Prolif. 51:2018.doi: 10.1111/cpr.12423.
View Article : Google Scholar
|
|
21
|
Lin J, Zhan Y, Liu Y, Chen Z, Liang J, Li
W, He A, Zhou L, Mei H, Wang F and Huang W: Increased expression of
ZEB1-AS1 correlates with higher histopathological grade and
promotes tumorigenesis in bladder cancer. Oncotarget.
8:24202–24212. 2017.PubMed/NCBI
|
|
22
|
Liu XJ, Li SL, Li JS, Lu H, Yin LL, Zheng
WF and Wang WC: Long non-coding RNA ZEB1-AS1 is associated with
poor prognosis in gastric cancer and promotes cancer cell
metastasis. Eur Rev Med Pharmacol Sci. 22:2624–2630.
2018.PubMed/NCBI
|
|
23
|
Liu C, Pan C, Cai Y and Wang H: Interplay
between long noncoding RNA ZEB1-AS1 and miR-200s regulates
osteosarcoma cell proliferation and migration. J Cell Biochem.
118:2250–2260. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang LL, Zhang LF, Guo XH, Zhang DZ, Yang
F and Fan YY: Downregulation of miR-335-5p by long noncoding RNA
ZEB1-AS1 in gastric cancer promotes tumor proliferation and
invasion. DNA Cell Biol. 37:46–52. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wei N, Wei H and Zhang H: Long non-coding
RNA ZEB1-AS1 promotes glioma cell proliferation, migration and
invasion through regulating miR-577. Eur Rev Med Pharmacol Sci.
22:3085–3093. 2018.PubMed/NCBI
|
|
26
|
Jin Q, Rui L, Wang YY, Shi Y, Luan WK, Tao
T, Zhang JX, Xu YC and You YP: MiR-1224-5p acts as a tumor
suppressor by targeting CREB1 in malignant gliomas. Mol Cell
Biochem. 403:33–41. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qian J, Li R, Wang YY, Luan WK, Tao T,
Zhang JX, Xu YC and You YP: MiR-1224-5p acts as a tumor suppressor
by targeting CREB1 in malignant gliomas. Mol Cell Biochem.
403:33–41. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yao X, Cui X, Wu X, Xu P, Zhu W, Chen X
and Zhao T: Tumor suppressive role of miR-1224-5p in keloid
proliferation, apoptosis and invasion via the TGF-β1/Smad3
signaling pathway. Biochem Biophys Res Commun. 495:713–720. 2018.
View Article : Google Scholar : PubMed/NCBI
|
